Augello Marcello, Furrer Thomas, Locher Michael
Poliklinik für Orale Chirurgie der Klinik für Zahn-, Mund- und Kieferkrankheiten und Kieferchirurgie der Universität Zürich.
Schweiz Monatsschr Zahnmed. 2009;119(8):809-17.
The purpose of this study was to determine the anesthetic efficacy of a intraosseous anesthesia (IOA) as an alternative to the infra alveolar nerve block (IANB) or the maxillary anesthesia. 55 subjects who underwent a tooth extraction received a primary X-tip intraosseous injection (LLC Lakewood, New Jersey, U.S.A.) of Ubistesin forte (articaini hydrochloridum 40 mg, adrenalinum 10 pg ut adrenalini hydrochloridum 1:100000, median 1.5 ml). A pulse oximeter measured the heart rate and the oxygen saturation. The results demonstrated, that the maximum heart rate was higher with the intraosseous injection (average 14.6 beats/min increase) during 1.5-2 minutes, but there was no depression of the oxygen saturation. The wound healing was uneventful. We registered five non-responders which were treated additionally with 1.3 ml of Ubistesin forte terminal anesthesia. For all patients the IOA was unpleasant similar to a "normal" anesthesia. Success of the intraosseous injection was 91%, comparable to the study of Turner et al. (2002) (or the clinical experience after an IANB). For non-responders to an IANB the IOA seems to be a good alternative method.
本研究的目的是确定骨内麻醉(IOA)作为下牙槽神经阻滞(IANB)或上颌麻醉替代方法的麻醉效果。55名接受拔牙的受试者接受了一次X型尖端骨内注射(美国新泽西州莱克伍德的LLC公司生产),注射药物为Ubistesin forte(盐酸阿替卡因40毫克,肾上腺素10微克,相当于盐酸肾上腺素1:100000,中位剂量1.5毫升)。脉搏血氧仪测量心率和血氧饱和度。结果表明,在1.5至2分钟内,骨内注射时的最高心率较高(平均增加14.6次/分钟),但血氧饱和度没有下降。伤口愈合顺利。我们记录了5名无反应者,对其额外使用1.3毫升Ubistesin forte进行终末麻醉。对所有患者而言,骨内麻醉与“常规”麻醉一样令人不适。骨内注射的成功率为91%,与特纳等人(2002年)的研究(或下牙槽神经阻滞后的临床经验)相当。对于下牙槽神经阻滞无反应者,骨内麻醉似乎是一种很好的替代方法。